| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Operating lease right-of-use assets | 5,476 | 5,812 | ||
| Other assets | 2,500 | - | ||
| Total assets | 362,741 | 194,598 | ||
| Accumulated other comprehensive income (loss) | 815 | 551 | ||
| Total stockholders' equity | 331,996 | 167,877 | ||
| Total liabilities and stockholders' equity | 362,741 | 194,598 | ||
Amylyx Pharmaceuticals, Inc. (AMLX)
Amylyx Pharmaceuticals, Inc. (AMLX)